日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metabolic dysfunction-associated steatotic liver disease is associated with vascular dysfunction in type 1 diabetes

代谢功能障碍相关的脂肪肝与1型糖尿病患者的血管功能障碍有关

Mertens, Jonathan; Stoop, Tibor; Dirinck, Eveline; Francque, Sven; Heuten, Hilde; De Block, Christophe

Management of obesity in advanced chronic liver disease

晚期慢性肝病肥胖症的管理

Caussy, Cyrielle; Francque, Sven M

International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG

关于脂肪胰的定义、诊断标准和治疗的国际多学科共识报告:由欧洲胰腺癌协会 (EPC)、美国胰腺病学会 (APA)、欧洲糖尿病研究协会 (EASD)、欧洲肝脏研究协会 (EASL)、欧洲胃肠病学会 (ESGAR)、欧洲胃肠内镜学会 (ESGE)、欧洲胰腺外科学会 (ESP)、欧洲胃肠病学和胃肠病学会 (ESPCG)、欧洲肠外肠内营养学会 (ESPEN)、欧洲儿科胃肠病学、肝病学和营养学会 (ESPGHAN)、国际儿科学会 (IAP)、日本胰腺外科学会 (JPS)、韩国胰腺和胆管癌协会 (KPBA)、洛杉矶胰腺外科和胃肠病学研究组 (LAPSG) 以及欧洲胃肠病学和胃肠病学学会 (UEG) 联合认可的声明。

Vujasinovic, Miroslav; Demir, Ihsan Ekin; Marchegiani, Giovanni; Hegyi, Peter; Archibugi, Livia; Valente, Roberto; Capurso, Gabriele; Witt, Heiko; Bonovas, Stefanos; Piovani, Daniele; Rosendahl, Jonas; Maisonneuve, Patrick; Verbeke, Caroline S; Karçaaltıncaba, Muşturay; Dominguez-Muñoz, J Enrique; Scheers, Isabelle; Czako, Laszlo; Wagner, Robert; Rebours, Vinciane; Öhlund, Daniel; Idilman, Ilkay S; Overbeek, Kasper; Gubergrits, Natalya; Engjom, Trond; Neesse, Albrecht; Apte, Minoti; Bezmarević, Mihailo; Braren, Rickmer; Bunduc, Stefania; Ceyhan, Güralp Onur; Chouhan, Manil Dinesh; Couvelard, Anne; Cros, Jérôme; Iglesia, Daniel de la; de-Madaria, Enrique; Drenth, Joost P H; Drewes, Asbjørn Mohr; Sarasqueta, Arantza Fariña; Fracasso, Pierluigi; Francque, Sven; Frøkjær, Jens Brøndum; Iglesias-Garcia, Julio; Garg, Pramod; Gerst, Felicia; Gulbinas, Antanas; Gürcinar, Ibrahim Halil; Heni, Martin; Hyun, Jong Jin; Jonas, Eduard; Kiriukova, Mariia; Kitano, Masayuki; Krag, Aleksander; Laukkarinen, Johanna; Lipp, Mónika; Lovecek, Martin; Martignoni, Marc; Masip, Etna; Matsumoto, Ryotaro; Molven, Anders; Mozhyna, Tetiana; Nosakova, Lenka; Obmann, Verena; Ockenga, Johann; Pandanaboyana, Sanjay; Panić, Nikola; Papachristou, Georgios; Pasqua, Analia Verónica; Pawlak, Katarzyna M; Pelaez-Luna, Mario; Regel, Ivonne; Regnér, Sara; Robinson, Stuart; Seicean, Andrada; Singh, Vijay; Smits, Mark M; Sung, Min Je; Tacelli, Matteo; Taylor, Roy; Teutsch, Brigitta; Udrescu, Mihaela; Wilschanski, Michael; Yavas, Aslihan; Zamboni, Giulia A; Löhr, J Matthias

MASLD Is Associated With Decreased General Health Perception, Quality of Life and Work Productivity in a Low Fibrosis Population

在低纤维化人群中,MASLD与总体健康感知、生活质量和工作效率下降相关。

Heyens, L J M; Van Steenkiste, C; Struyve, M; Francque, S M; Koek, G H; Robaeys, G

Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease

代谢功能障碍和酒精相关性肝病(MetALD):酒精相关性肝病专家组的立场声明

Arab, Juan Pablo; Díaz, Luis Antonio; Rehm, Jürgen; Im, Gene; Arrese, Marco; Kamath, Patrick S; Lucey, Michael R; Mellinger, Jessica; Thiele, Maja; Thursz, Mark; Bataller, Ramon; Burton, Robyn; Chokshi, Shilpa; Francque, Sven M; Krag, Aleksander; Lackner, Carolin; Lee, Brian P; Liangpunsakul, Suthat; MacClain, Craig; Mandrekar, Pranoti; Mitchell, Mack C; Morgan, Marsha Y; Morgan, Timothy R; Pose, Elisa; Shah, Vijay H; Shawcross, Debbie; Sheron, Nick; Singal, Ashwani K; Stefanescu, Horia; Terrault, Norah; Trépo, Eric; Moreno, Christophe; Louvet, Alexandre; Mathurin, Philippe

Increased prevalence and risk of atherosclerotic cardiovascular disease in individuals with Type 1 diabetes and metabolic dysfunction-associated steatotic liver disease

型糖尿病合并代谢功能障碍相关脂肪肝患者的动脉粥样硬化性心血管疾病患病率和风险增加

Mertens, Jonathan; Weyler, Jonas; Dirinck, Eveline; Vonghia, Luisa; Kwanten, Wilhelmus J; Van Gaal, Luc F; De Winter, Benedicte Y; Francque, Sven; De Block, Christophe

Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD

肝脏诊断的精确性:不同亚组的准确率存在差异,以及在MASLD诊断中需要采用不同的阈值。

Vali, Yasaman; van Dijk, Anne-Marieke; Lee, Jenny; Boursier, Jerome; Ratziu, Vlad; Yunis, Carla; Schattenberg, Jörn M; Valenti, Luca; Gomez, Manuel Romero; Schuppan, Detlef; Petta, Salvatore; Allison, Mike; Hartman, Mark L; Porthan, Kimmo; Dufour, Jean-Francois; Bugianesi, Elisabetta; Gastadelli, Amalia; Derdak, Zoltan; Fournier-Poizat, Celine; Shumbayawonda, Elizabeth; Kalutkiewicz, Michael; Yki-Jarvinen, Hannele; Ekstedt, Mattias; Geier, Andreas; Trylesinski, Aldo; Francque, Sven; Brass, Clifford; Pavlides, Michael; Holleboom, Adriaan G; Nieuwdorp, Max; Anstee, Quentin M; Bossuyt, Patrick M

Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration

DNA甲基化的渐进性变化揭示了与代谢功能障碍相关的脂肪肝疾病进展和表观遗传年龄加速有关的转录因子。

Van Dijck, Evelien; Van Laere, Steven; Logie, Emilie; Timmermans, Steven; Fransen, Erik; Ibrahim, Joe; Kendall, Timothy J; Fallowfield, Jonathan A; Mateiu, Ligia M; Libert, Claude; Van Camp, Guy; Verrijken, An; Van Gaal, Luc; Francque, Sven; Van Hul, Wim; Berghe, Wim Vanden

Increased 1-deoxysphingolipids caused by an altered plasma alanine to serine ratio are associated with metabolic dysfunction-associated steatotic liver disease (MASLD)

血浆中丙氨酸与丝氨酸比例改变引起的 1-脱氧鞘脂增加与代谢功能障碍相关性脂肪肝病 (MASLD) 相关。

Wipfli, F; A Lone, M; von Eckardstein, A; Verrijken, A; Francque, S; Weyler, J; Van Gaal, L; Staels, B; Hornemann, T

Close multilevel links between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus

代谢功能障碍相关脂肪肝与2型糖尿病之间存在密切的多层次联系

Holleboom, A G; Francque, S M; Cusi, K; Caussy, C